A phase 1, multicenter, open-label, dose-escalation study of SGN 2FF in patients with advanced solid tumors

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
A phase 1, multicenter, open-label, dose-escalation study of SGN 2FF in patients with advanced solid tumors

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.